Expert insights and in-depth tips on stocks, commodities, and cryptocurrencies to help you navigate volatile markets and make informed investment decisions.
Down 51% from October 2025 highs on crypto cooling and fintech multiple compression - yet full-year 2025 revenue hit $4.5B (+52% YoY), net income reached $1.9B, Gold subscribers crossed 4.2M, and platform assets surged to $324B. 11 business lines now exceed $100M ARR. Forward P/E at 29x with 28.9% forward revenue growth and a PEG of 1.82 - half of Coinbase's growth-adjusted multiple. R/R: ~1:2.5.
Down 50%+ from its 2025 highs on SaaSpocalypse fears - but revenue reaccelerates to 26%, FCF margin hits 52%, Z-Flex bookings surge 65%+ Q/Q, and AI Security ARR crosses $400M three quarters ahead of schedule. EV/Revenue at 8x - the lowest in company history versus a 5-year median of 15.3x. ZS is cheaper than CRWD, NET, and PANW on every valuation metric despite faster 5-year growth. R/R: ~1:2.9.
$216B FY2026 revenue (+65% YoY), $97B free cash flow, Q4 beat on all metrics - yet stock fell 5%. Post-earnings mispricing thesis: NVDA trades at a discount to sector median (PEG 0.66) while guiding $78B for Q1. Vera Rubin architecture arriving H2 2026 with 10× inference cost reduction.
Coupang controls ~40% of South Korea's e-commerce market with a logistics moat that took $10B+ to build. Down ~50% from 2025 highs on a data breach - a fixable compliance event, not a broken business. At 0.85× EV/Sales with triple-digit Taiwan growth and institutional accumulation from Norges Bank & RIT Capital, the risk/reward is compelling. R/R: ~1:2.7.
Record $12.68B Q2 revenue (+123% YoY) as SMCI transitions from server vendor to full-stack AI infrastructure provider. Non-GAAP GM compressed to 6.4% - but DCBBS solutions at 20%+ margins are scaling to double-digit profit contribution by end-2026. Trading at <0.5× forward P/S vs. 3.5× sector average. Hyperscaler CapEx exceeding $600B in 2026 provides the demand floor. R/R: ~1:2.5.
CleanSpark runs 50 EH/s at a $43,000 cost per Bitcoin, holds 13,000+ BTC on the balance sheet, and is sitting on 1+ GW of contracted US power that hyperscalers are now calling about directly. At 11× forward earnings - a 63% discount to AI-pivot peers - the market is paying nothing for the second act. FY2025 revenue $766M (+100% YoY), 55% gross margin, net income $365M. R/R: ~1:2.9.
Europe's largest gas supplier at 8.8x forward P/E with ~8% dividend yield. Production up 7% YoY to 2,130 MBOE/d. European gas storage 10% below 5-year average heading into winter. ~$9B shareholder returns (~15% yield). Balance sheet holds $22.4B cash, 12.2% net debt. Dual catalyst: gas tightening + oil repricing. R/R: ~1:2.8.
A ~10.3% yield backed by 107 Nasdaq-100 names, with a monthly covered call overlay that converts volatility into income. Beta 0.78, std dev 13.79 vs 19.09 for QQQ. At $56–$58 - 5% below the November high - the yield-on-cost improves and the SMA200 provides a defined floor. Base case: choppy 2026 where covered calls outperform unhedged Nasdaq exposure. R/R: ~1:2.0 on total return.
World's largest iron ore producer trading near multi-year lows. C1/t cost at $20.7/t - guidance achieved, bear narrative broken. ~14% FCF yield, dam liabilities 75% settled, extraordinary dividend trigger approaching $15B net debt. US-China tariff truce + Lunar New Year restocking support near-term. R/R: ~1:2.6.
Trading at ~1× its own FY2025 EBITDA ($2.0B–$2.2B guided) with $3B liquidity vs. ~$1.9B market cap. Suez Canal return imminent, US-China trade deal tailwind, MBO optionality, and $47.54/share in cumulative dividends since IPO. R/R: ~1:2.6.
Five acquisitions in 90 days building detect-to-defeat counter-UAS architecture. Q3 2025 record $10.1M revenue (+582% YoY). $840M cash war chest. European airport deployments imminent. $110M 2026 guidance. Analyst consensus PT $19. R/R: ~1:3.0.
Exxon trades at a historically low P/Cash multiple while the market fixates on oil weakness. Cold winter NG catalyst could add $0.90–$1.10 EPS. Guyana at 900Mboe/d and rising, Golden Pass LNG permitted, $9.8B buybacks in H1 2025. Dividend yield above historical average at 3.5%. R/R: ~1:3.0.
Fully permitted copper-palladium project in Ontario with C$1.07B after-tax NPV (28% IRR, 1.9yr payback). Wheaton stream signed, US$400M senior debt mandated. Palladium surging 83%+ in 2025, US AD/CVD action against Russian supply. Only near-construction Western primary palladium source. R/R: ~1:3.0.
Q2 2025 revenue $20.7M (+81.6% YoY, beat consensus by 20%). Tempo achieves world-first 99.99% two-qubit fidelity and #AQ 64 ahead of schedule. $1.6B cash. AstraZeneca 20× drug sim speedup. JPMorgan quantum head hired. $82–$100M 2025 guidance raised. R/R: ~1:2.7.
Only FAA-certified BVLOS drone in the US. Revenue up 555% YoY. OBBB unlocks $21.3B defence drone TAM. $14.3M record Optimus order, DMS manufacturing partnership, convertible debt retired. Hedge funds added 9.9M shares. $110M 2026 guidance. R/R: ~1:3.5.
50 EH/s complete at $25,647/BTC (half of MARA's cost). Mining paused - all capital redirected to AI. Horizon 1 data centre delivers Q4 2025, targeting 10,900 GPUs & $200-250M AI ARR. 74% mining margins, 128% YoY revenue growth, Sweetwater Hub valued at $32/share. R/R: ~1:3.3.
BMY trades at its cheapest valuation in a decade - 6.7x forward P/E vs. a 15x sector median - while its growth portfolio (Opdivo, Reblozyl, Camzyos, Cobenfy) has already reached revenue parity with its declining legacy business. $13–15B in annual FCF, a 5.3% dividend covered 2.6× by cash flow, and an $11B BioNTech pipeline deal targeting $375B in oncology markets. The market is pricing in worst-case legacy erosion; I'm betting on the re-rating when the transition becomes undeniable. R/R: ~1:2.5.
America's largest licensed uranium producer - 12.1M lbs/yr US capacity, 1.36M lbs physical inventory, zero debt, $271M liquid assets. Q2 revenue $49.8M at $82.92/lb. 95% of US uranium is imported. Four executive orders + Big Beautiful Bill mandate a domestic nuclear revival. UEC is the only company with permitted ISR hubs already producing. R/R: ~1:2.8.
TLT trades near its 2008 crisis lows at $84–$85 while Goldman Sachs places recession probability at 45%. With 16.13-year effective duration, each 1% yield decline translates to ~16% price appreciation. A 4.51% yield cushions the wait. Real rate framework and three scenarios - plus TLTW as an income-enhanced variant for yield-first investors. R/R: ~1:2.5.
e.l.f. Beauty fell 77% from its $218 peak while delivering 24 consecutive quarters of revenue and market share growth. #1 mass cosmetics brand in the US by units, 71% gross margins, $500M buyback (17% of market cap), and a PPO crossover from deeply oversold -20 territory. The selloff was macro fear, not business failure. R/R: ~1:2.8.
Bitcoin breaks above $93k exactly 12 months post-halving - the historical sweet spot for cycle peaks. Spot ETF AUM surpasses $50B, absorbing 100%+ of daily new supply. Target: $118k-$120k in 3-6 months.
ISG revenue +22% YoY, AI server backlog $9B and growing every quarter, $15B+ guided for FY26. The stock sits at 9× forward earnings while margins expand and a forced Windows 11 PC refresh cycle approaches. Two independent growth engines - both discounted to zero. Goldman Sachs Buy, $130 target. R/R: ~1:2.7.
$99M net cash, zero debt, 40-year dividend streak. EV of just $300M. In 2026, a $204M Hawaii seawater desalination contract breaks ground - potentially generating 20% of enterprise value in earnings in 24 months. Recurring O&M revenues up 51% YoY. The stock has pulled back from $40 to the $24 entry zone. R/R: ~1:2.1.
America's largest natural gas producer cut its breakeven to $2.03/Mcfe after the Equitrans acquisition collapsed gathering costs 84%. $2.6B free cash flow in 2025, $5.25B in asset sales above target, Blackstone JV for creative deleveraging, well productivity pulling away from every Appalachian peer, and a hedge book shaped for gas price upside. Four independent analytical frameworks converge on the same conclusion. R/R: ~1:2.5.
100% EUV monopoly trading at 29.3x forward P/E - precisely its 13-year average - while Q4 bookings doubled consensus at EUR 7.1B. $315B+ in hyperscaler CapEx committed for 2025, High-NA maturing ahead of plan, 2nm ramp starting. EUR 36B backlog provides 5.5 quarters of visibility. R/R: ~1:2.5.
Two data events knocked AMGN ~20% off its highs. At 14.3x forward earnings with 23% YoY revenue growth, 33% net margins, and 12 consecutive dividend hikes, the market prices MariTide at zero. Phase II: up to 20% weight loss at 52 weeks without a plateau, 90% patient retention, bone density concern resolved. Monthly dosing vs. weekly competitors. Amgen market cap $150B vs. Lilly+Novo $1.18T combined. Analyst PTs: $215–$405. R/R: ~1:2.5 base case.
9M 2024 EBITDA $1.0B+ (+46% YoY), FY guidance upper end $1.45B confirmed. $630M PEC receivables factored same day. First Metropolitan BESS (67 MW) launched. Los Condores 150 MW hydro imminent. Nov 21 Strategic Plan: +12% USD dividend. 8,700 MW, 77% renewable, BBB+. R/R: ~1:2.6 + 7% yield.
Fed's first rate cut in 4 years narrows the staking yield gap. $502M staking surge in 72 hours post-CPI, 34.32M ETH staked across 1.07M validators at 4.6% yield, MVRV at ten-month lows, and L2 cannibalization paradox framing a contrarian setup. Three scenarios from $1,800 bear to $4,200 bull with on-chain confirmation signals.
World's lowest-cost lithium producer (~$5K/MT) at an 87% price collapse from peak. Q2 2024 trough earnings still show 16.5% net margin and record 52K MT volumes. Codelco JV removes 2030 license risk - operations secured to 2060. Forward EBITDA at 6.5× vs 10× historical average. R/R: ~1:4.5.
Q2 2024 EBITDA +20.5% YoY. WTG Midstream closed. Triple investment-grade credit. 1.86× distribution coverage on 8.3% yield. Trading at 20% discount to peers on EV/EBITDA. AI/data centre gas demand in early innings. R/R: ~1:2.4 + 8% yield.
$21.1B backlog (7-year high), S&P upgrade to BBB−, four growth engines firing simultaneously. Boeing stumbles, Airbus sold out - and the world’s 3rd-largest planemaker enters “harvest mode.” NetJets options worth ~$5B not in backlog. C-390 targeting $60B TAM. Services margin at 15%. R/R: ~1:3.5.
Q1 revenue $36.5B (+27% YoY), operating margins expanded from 25% to 38%, EPS beat by $0.35 - yet the stock dropped 10% on higher CapEx guidance. AI already driving 50%+ of Instagram content, Advantage+ revenue doubled. 3.24B daily users, $49B FCF, 21x FY25 P/E. R/R: ~1:3.5.
Q1 revenue -8.7%, worst quarter in years - but FSD miles surpassing 1 billion parabolically, China regulatory approval imminent for 2M+ installed base, Model 2 at ~$30K reshaping the category, and Energy/Megapack scaling toward a multi-hundred-billion business. Lowest valuation in 5 years. R/R: ~1:3.5.
Halving just 6 days ago. Zero debt, $321M cash, 9.4 EH/s growing to 30 EH/s with fixed-price T21 contracts at $14/TH. 816 NVIDIA H100 GPUs live, ERCOT energy arbitrage algorithm, and institutional backing from Marshall Wace, Millennium, Morgan Stanley. Trades at 55-65% discount to peers. R/R: ~1:4.0.
AWS margins reflating (29.6% Q4), retail turned profitable (+2.5% EBIT), advertising at $47B run-rate. At 18.7× adj. OCF - 28% below 5-year avg - the market has priced recovery but not the operating leverage ahead. AI catalyst just beginning. R/R: ~1:2.3.
Spot ETF just approved (4 weeks ago), halving 10 weeks away. 1.618 Fib extension, Stock-to-Flow post-halving repricing, and on-chain terminal price all converge on $90,000. R/R: ~1:5.5.
PolyMarkets Investment Strategies is a team of independent investment professionals pulling back the curtain on elite global market research - sophisticated studies and papers typically reserved for major institutions, hedge funds, and top money managers.
We distill complex research into clear, in-depth insights so you can spot tomorrow's winners before they hit mainstream radar.
No more guesswork. No more being the last to know.
Get upfront access to undiscovered trends shaping future markets - and success to make informed decisions.
Develop a deeper understanding of markets. Explore strategies for long-term wealth building. Learn how passive income streams and compounding work - step by step.
Our research articles and educational content are our own materials and therefore completely free - subscribe to get notified the moment we publish a new piece. Market Tips, our flagship product, go deeper. Each one draws on professional paper reports, quantitative research databases, and institutional-grade analysis - resources that carry real cost to source. That's why Market Tips are exclusive to our premium members - an affordable subscription that gives you a similar calibre of insight the big players pay a fortune for.
Your insider edge starts here. Join our premium community today.